JAK/STAT 信号通路是细胞因子受体信号转导的核心,细胞因子受体是由 30 多种跨膜蛋白组成的超家族,可以识别特定的细胞因子,在血液形成和免疫应答中起关键作用。典型的 JAK/STAT 信号通路始于细胞因子及其相应的跨膜受体的结合。活化的 JAKs 随后磷酸化 STAT 单体,导致其二聚化、核易位和 DNA 结合。在哺乳动物中,有 4 种 JAK (JAK1, JAK2, JAK3, TYK2) 和 7 种 STATs (STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b, STAT6)。由于 JAK/STAT 通路在细胞凋亡、炎症等过程中起着重要作用,因此该信号通路的功能失调可能导致多种疾病的发生。如,JAK/STAT信号的改变可能导致癌症和免疫系统疾病,如严重综合型免疫缺乏症 (SCID)。
Chem960 提供 JAK/STAT 信号通路相关小分子抑制剂化合物,可以用于 JAK/STAT 信号通路研究及相关疾病研究。
• A unique collection of 585 bioactive compounds related to JAK/STAT signaling used for high throughput screening (HTS) and high content screening (HCS).
• Targets include JAK, STAT, EGFR, Pim, etc.
• A useful tool for JAK/STAT-related drug discovery.
• Bioactivity and safety confirmed by preclinical research and clinical trials. Some inhibitors have been approved by FDA.
• Structurally diverse, medicinally active, and cell permeable.
• More detailed compound information with structure, IC50, and brief introduction.
• NMR and HPLC validated to ensure high purity and quality.
• All compounds are in stock and continuously updated.